Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rudd

Showing results (61-70 of 496) with videos related to

Pageof 50
Sort By:
Immunity|April 20, 2017
Two Strings in One Bow: PD-1 Negatively Regulates via Co-receptor CD28 on T CellsJanna Krueger, Christopher E Rudd
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|September 4, 2007
Stevens's brightness law, contrast gain control, and edge integration in achromatic color perception: a unified modelMichael E Rudd, Dorin Popa
Frontiers in Immunology|December 25, 2014
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4Helga Schneider, Christopher E Rudd
Journal of Bacteriology|June 1, 1992
Physical map location of the argFGH operon of Escherichia coliW Hendrickson, K E Rudd
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Hematopoietic adaptors in T-cell signaling: potential applications to transplantationChristopher E Rudd, Hongyan Wang
Current Biology : CB|May 10, 2000
Lymphocyte signaling: Cbl sets the threshold for autoimmunityC E Rudd, H Schneider
Advances in Experimental Medicine and Biology|October 3, 2019
Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer ImmunotherapyAlison Taylor, Christopher E Rudd
Neuron|December 17, 2009
The challenges natural images pose for visual adaptationFred Rieke, Michael E Rudd
Psychological Review|January 1, 1992
Cortical dynamics of visual motion perception: short-range and long-range apparent motionS Grossberg, M E Rudd
Frontiers in Immunology|January 10, 2018
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8<sup>+</sup> Cytotoxic T-Cells: Implications for anti-PD-1 ImmunotherapyAlison Taylor, Christopher E Rudd
Pageof 50

Showing results (61-70 of 496) with videos related to

Sort By:
Pageof 50
Immunity|April 20, 2017
Two Strings in One Bow: PD-1 Negatively Regulates via Co-receptor CD28 on T CellsJanna Krueger, Christopher E Rudd
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|September 4, 2007
Stevens's brightness law, contrast gain control, and edge integration in achromatic color perception: a unified modelMichael E Rudd, Dorin Popa
Frontiers in Immunology|December 25, 2014
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4Helga Schneider, Christopher E Rudd
Journal of Bacteriology|June 1, 1992
Physical map location of the argFGH operon of Escherichia coliW Hendrickson, K E Rudd
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2003
Hematopoietic adaptors in T-cell signaling: potential applications to transplantationChristopher E Rudd, Hongyan Wang
Current Biology : CB|May 10, 2000
Lymphocyte signaling: Cbl sets the threshold for autoimmunityC E Rudd, H Schneider
Advances in Experimental Medicine and Biology|October 3, 2019
Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer ImmunotherapyAlison Taylor, Christopher E Rudd
Neuron|December 17, 2009
The challenges natural images pose for visual adaptationFred Rieke, Michael E Rudd
Psychological Review|January 1, 1992
Cortical dynamics of visual motion perception: short-range and long-range apparent motionS Grossberg, M E Rudd
Frontiers in Immunology|January 10, 2018
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8<sup>+</sup> Cytotoxic T-Cells: Implications for anti-PD-1 ImmunotherapyAlison Taylor, Christopher E Rudd
Pageof 50